TRAM1
Translocating chain-associated membrane protein 1
Also known as: TRAM, TRAM1_HUMAN, TRAMP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15629
- Gene
- TRAM1
- Ensembl
- ENSG00000067167
- Chromosome
- 8
- Canonical length
- 374 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a multi-pass membrane protein that is part of the mammalian endoplasmic reticulum. The encoded protein influences glycosylation and facilitates the translocation of secretory proteins across the endoplasmic reticulum membrane by regulating which domains of the nascent polypeptide chain are visible to the cytosol during a translocational pause. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
374 residues, UniProt reviewed canonical sequence.
>Q15629|TRAM1
1 MAIRKKSTKS PPVLSHEFVL QNHADIVSCV AMVFLLGLMF EITAKASIIF VTLQYNVTLP
61 ATEEQATESV SLYYYGIKDL ATVFFYMLVA IIIHAVIQEY MLDKINRRMH FSKTKHSKFN
121 ESGQLSAFYL FACVWGTFIL ISENYISDPT ILWRAYPHNL MTFQMKFFYI SQLAYWLHAF
181 PELYFQKTKK EDIPRQLVYI GLYLFHIAGA YLLNLNHLGL VLLVLHYFVE FLFHISRLFY
241 FSNEKYQKGF SLWAVLFVLG RLLTLILSVL TVGFGLARAE NQKLDFSTGN FNVLAVRIAV
301 LASICVTQAF MMWKFINFQL RRWREHSAFQ APAVKKKPTV TKGRSSKKGT ENGVNGTLTS
361 NVADSPRNKK EKSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 183 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 183 nTPM
- liver: 178 nTPM
- pancreas: 166 nTPM
- thyroid gland: 160 nTPM
- epididymis: 140 nTPM
- lung: 138 nTPM
Single-cell type
- alveolar cells type 1: 1,042 nCPM
- plasma cells: 628 nCPM
- transitional alveolar cells: 444 nCPM
- alveolar cells type 2: 439 nCPM
- late spermatids: 386 nCPM
- esophageal apical cells: 353 nCPM
Immune cell
- total PBMC: 232 nTPM
- plasmacytoid DC: 191 nTPM
- MAIT T-cell: 154 nTPM
- basophil: 151 nTPM
- T-reg: 147 nTPM
- memory CD8 T-cell: 138 nTPM
Brain region
- choroid plexus: 78 nTPM
- white matter: 48 nTPM
- medulla oblongata: 46 nTPM
- hypothalamus: 43 nTPM
- thalamus: 39 nTPM
- spinal cord: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.93
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cotranslational protein targeting to membrane
- protein insertion into ER membrane
- response to unfolded protein
- SRP-dependent cotranslational protein targeting to membrane, translocation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAM1 as an antibody target. Whether an autoantibody or antibody against TRAM1 could matter depends on whether native TRAM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...